Abstract:Lu Chen, 1, &ast Yu Zhong, 2, &ast Yong-Sheng Li, 3 He Zhuang, 4 Xin Li, 5 Sheng-Ping Liu, 5 Jing-Gang Li, 5 Qiu Lin, 4 Fei Gao 5 1 Department of Paediatrics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350000, People's Republic of China; 2 Department of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, 350122, People's Republic of China; 3 Department of Urology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 4 Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 5 Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Gao, Email Background: Accurate, sensitive, and rapid identification of leukemia cells in blood and bone marrow is of paramount significance for clinical diagnosis. An integrative technique combining traditional cytomorphology with immunophenotyping was proposed to improve the diagnostic efficiency in leukemia. On account of high photostability, biocompatibility, and signal-to-background ratio, upconversion nanoparticles (UCNPs) as luminescent labels have drawn substantial research scrutiny in immunolabeling. Methods: To achieve simultaneous determination, NaYF 4 :Yb,Er UCNPs were coupled with CD38 antibodies to construct immunofluorescence probes that were developed to bind to diffuse large B cell lymphoma (DLBCL) cells, followed by Wright's staining that has been widely used in clinical work for morphological diagnosis. Further, the experimental conditions were optimized, such as medium, slice-making method, antibody dosage, incubation time, etc. Results: The cell morphology and immunolabeling could be observed simultaneously, and its simple operation rendered it a possibility for clinical diagnosis. The developed immunolabeling assay could achieve DLBCL cell counting with high reproducibility and stability, and the detection limit was as low as 1.54 cell/slice (> 3 σ/s). Moreover, the proposed method also realized real blood and bone marrow sample analysis, and the results were consistent with the clinical diagnosis. Conclusion: Overall, this strategy can be carried out after simple laboratory training and has prospective biomedical applications in leukemia classification, diagnosis validation, and differential diagnostics. Graphical Keywords: leukemia, upconversion nanoparticle, immunofluorescence probe, Wright's staining, cytomorphology Graphical Leukemia, a generic term, encompasses several life threatening malignant disorders that present with incremental amounts of leucocytes in blood and bone marrow. Leukemia cells have the innate ability for migration and invasion. 1 Dedifferentiated and malignant leucocytes not only retain the benign leucocytes capacity for cell motility and survival in the circulation, but obtain the potential for rapid and uncontrolled cell division. 1 Accordingly, leukemia is aggressive and is a challenging disease to treat. Regrettably, leukemia may occur at all ages from the newborn to the aged with different forms and various age distributions. 2 Rapid and accurate diagnosis of leukemia is vital to prevent disease progression and reduce mortality. Currently, the common diagnostic techniques toward leukemia principally lean on cytomorphology, cytochemistry, immunophenotyping (flow cytometry, FCM), cytogenetics (chromosome analysis and fluorescence in situ hybridization), and molecular genetics (polymerase chain reaction and sequencing technique). 3–5 Regrettably, there is a shortage of FCM equipment, and other cytogenetics and molecular genetics methods available at laboratory diagnostic centers require expensive equipment, experienced personnel, immediate processing, tedious operation, and so on. 6,7 Correspondingly, cytomorphology is an indispensable approach in hematological disease diagnosis owing to its fast evaluation of specimens, thus endowing time-saving and cost-effective characteristics. Specifically, trained hematologists can distinguish abnormalities in cell morphology or potential leukemia cells from normal counterparts. 8 Further, assessment of the percentage and relative distribution of erythropoiesis, granulopoiesis, and monocytopoiesis can identif -Abstract Truncated-

A convolutional neural network‐based, quantitative complete blood count scattergram‐mapping framework promptly screens acute promyelocytic leukemia with high sensitivity

Immunophenotypic Analysis and Rapid Diagnosis of Acute Promyelocytic Leukemia by Flow Cytometry.

An End-to-End Pipeline for Early Diagnosis of Acute Promyelocytic Leukemia Based on a Compact CNN Model

A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia

Diagnosing acute promyelocytic leukemia by using convolutional neural network

AMLnet, A Deep-Learning Pipeline for the Differential Diagnosis of Acute Myeloid Leukemia from Bone Marrow Smears.

Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia

CAE-ResVGG FusionNet: A Feature Extraction Framework Integrating Convolutional Autoencoders and Transfer Learning for Immature White Blood Cells in Acute Myeloid Leukemia

Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features

A Segmentation Method Based on HMRF for the Aided Diagnosis of Acute Myeloid Leukemia

Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry

Flow Cytometric Analysis of CD64 Expression Pattern and Density in the Diagnosis of Acute Promyelocytic Leukemia: a Multi-Center Study in Shanghai, China

Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry

Diagnosis and typing of leukemia using a single peripheral blood cell through deep learning

Measurable Residual Disease Analysis by Flow Cytometry and Correlation With Molecular Measurable Residual Disease in Acute Promyelocytic Leukemia: A Real-World Prospective Study

Usefulness of Cd11a and Cd18 in Flow Cytometric Immunophenotypic Analysis for Diagnosis of Acute Promyelocytic Leukemia

Deep learning model for differentiating acute myeloid and lymphoblastic leukemia in peripheral blood cell images via myeloblast and lymphoblast classification

A Novel and Rapid Smear Cytomorphology Detection Strategy Based on Upconversion Nanoparticles Immunolabeling Integrated with Wright's Staining for Accurate Diagnosis of Leukemia

The Clinical and Laboratory Features of Acute Promyelocytic Leukemia: an Analysis of 513 Cases

Clinically Useful Flow Cytometry Approach to Identify Immunophenotype in Acute Leukemia

Feature Fusion Based Ensemble of Deep Networks for Acute Leukemia Diagnosis Using Microscopic Smear Images